Reporting of adverse events ONLY

Patients should always seek the advice of a doctor or pharmacist in case of adverse events.

If you wish to report an adverse event to ELC Group s.r.o., please find the contact information below:

00420 224 910 672

(from 09.00-17.30 CET)

00420 723 694 460

(non-stop 24/7)

To contact us about any other issue please call:

+420 22 491 0000or our regional offices.

Hlášení nežádoucích príhod

Pacienti by meli vždy požádat o radu svého lékare nebo lékárníka v prípade výskytu nežádoucích príhod.

Pokud chcete nahlásit nežádoucí príhodu spolecnosti ELC Group s r.o., prosím využijte kontaktních údaju níže:

00420 224 910 672

(09.00-17.30 CET)

00420 723 694 460

(non-stop 24/7)

Pro záležitosti, které se netýkaji farmakovigilance, kontaktujte prosím recepci:

+420 22 491 0000 nebo naše další pobočky.

About us

ELC集团在全球多个领域都是值得信赖的伙伴,通过以下四个专业范畴为全世界各地的项目提供一系列解决方案:制药,医疗器械,翻译,化学品。ELC集团拥有一支近150名专业人员的团队(来自30个国家以及使用20多种语言),目前在60多个国家开展项目,因此我们很自豪地称自己为一家全球真正的全球性集团。

850+
客户
11,000
个已完成项目
60+
国家

我们的优势

Industry expertise

Many of ELC’s 150 professionals have worked in the same industries that we deal with on a daily basis. Their experience and “insider knowledge” is invaluable for our clients as it enables us to achieve the necessary tasks in the most efficient, cost-effective way possible.

Network of experts

For the Pharmaceutical and the Medical Device divisions, ELC experts and project managers collaborate with 160 external collaborators (among which many ex-assessors from the national competent authorities and local experts in regulation requirements), allowing us to cater to different needs while optimising costs.

Concerning the Translation division, we do work with several hundreds of translators and proofreaders.

First-rate project management

All of our projects are carefully managed by experienced project managers to ensure expedited project results without sacrificing quality.

Open communication

We understand the importance of keeping the channels of communication open with our clients. This means we keep them informed every step of the way and we welcome their input and participation.

Flexibility

Some projects involve taking a product from development all the way through to commercialisation, others require only specialised attention in certain areas. No matter the nature or scale of a project, our commitment to quality remains the same.

Informed leadership

ELC’s leadership makes a concerted effort to stay abreast of all current industry trends and innovations. If there is a better way to do things, we will a) know about it and b) put it into practice as quickly as possible.

Our journey so far

Over the last 15 years, ELC has experienced significant growth and transformation. We started as a translation pure-player company, and soon after we entered the pharmaceutical market, we moved to the medical device and chemical ones as well. We learnt to adapt fast to new challenges, new industries and new requirements, we have been continuously growing and covering new activities.

In the pharmaceutical industry, for example, we have been one of the first organisations to bring non-EU companies into the EU market by assisting them with the new EU regulations for drug registrations.

We also recognised the complex difficulties faced by our clients in the area of pharmacovigilance (PV) which led to us offering PV services in 2010. As the industry has developed, vertical integration has proved necessary, which is one of the reasons ELC has expanded into formulation development.

2018-19 was a period of major restructuring within the company which has resulted in improved processes (refined and streamlined) and increased efficiency.

We will continue to adapt and grow in any way necessary to meet the demands of our clients.

Where we work

With six offices in five countries around the world (Czech Republic, India, Romania, UK, US) ELC is currently partnering with over 500 clients in more than 60 countries.